Back to Infectious Disease
Infectious DiseasevVACS 1.0Evidence-Based

Veterans Aging Cohort Study (VACS) 1.0 Index

Estimates 5-year all-cause mortality risk in patients with HIV and/or HCV by integrating HIV-specific biomarkers (CD4 count, HIV-1 RNA) with general health indicators (hemoglobin, liver function, kidney function, and hepatitis C co-infection).

Clinical Input Parameters

years
Range: 18 — 120 years
cells/mm³
Range: 0 — 5000 cells/mm³
copies/mL
Range: 0 — 10000000 copies/mL
g/dL
Range: 3 — 25 g/dL
index
Range: 0 — 50 index
mL/min/1.73m²
Range: 0 — 200 mL/min/1.73m²
Clinical Assessment
Awaiting Parameters
vacs score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Veterans Aging Cohort Study (VACS) 1.0 Index is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within infectious disease.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

VACS 1.0 Index = Age points + CD4 points + HIV RNA points + Hemoglobin points + FIB-4 points + eGFR points + HCV points Age: <50y=0, 50-64y=12, ≥65y=27 CD4: ≥500=0, 350-499=6, 200-349=6, 100-199=10, 50-99=28, <50=29 HIV RNA: <500=0, 500-99999=7, ≥100000=14 Hemoglobin: ≥14=0, 12-13.9=10, 10-11.9=22, <10=38 FIB-4: <1.45=0, 1.45-3.25=6, >3.25=25 eGFR: ≥60=0, 45-59.9=6, 30-44.9=8, <30=26 HCV: No=0, Yes=5

Clinical Pearls & Practice Notes

  • The VACS 1.0 Index has been validated in diverse HIV+ populations including both veterans and non-veterans.
  • Higher scores indicate increased 5-year all-cause mortality risk.
  • The index integrates both HIV-specific markers and general health biomarkers for comprehensive risk assessment.
  • FIB-4 Index calculation: (Age × AST) / (Platelet count × √ALT). Values >3.25 suggest advanced liver fibrosis.
  • This tool is most accurate in patients with at least 1 year of antiretroviral therapy exposure.
  • The VACS Index has shown better discrimination than HIV markers alone (C-statistic 0.77 vs 0.74).

Evidence & Literature Citations

  1. Justice AC, McGinnis KA, Skanderson M, et al. Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers. HIV Med. 2010;11(2):143-151.
  2. Tate JP, Justice AC, Hughes MD, et al. An internationally generalizable risk index for mortality prediction in HIV-infected adults. AIDS. 2013;27(4):563-572.
  3. Justice AC, Dombrowski E, Conigliaro J, et al. Veterans Aging Cohort Study (VACS): Overview and description. Med Care. 2006;44(8 Suppl 2):S13-24.

Score Interpretation Ranges

Low Risk0 – 20 pts

Low 5-year mortality risk

Moderate Risk21 – 40 pts

Moderate 5-year mortality risk

High Risk41 – 60 pts

High 5-year mortality risk

Very High Risk61 – 150 pts

Very high 5-year mortality risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.